Perimeter Medical Imaging AI, Inc.
PYNKF
$0.29
$0.00020.07%
| Weiss Ratings | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.25 | |||
| Price History | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.94% | |||
| 30-Day Total Return | -27.50% | |||
| 60-Day Total Return | -9.38% | |||
| 90-Day Total Return | -24.68% | |||
| Year to Date Total Return | -7.56% | |||
| 1-Year Total Return | -50.59% | |||
| 2-Year Total Return | -76.94% | |||
| 3-Year Total Return | -87.16% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -54.75% | |||
| 52-Week Low % Change | 31.41% | |||
| Price | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.64 | |||
| 52-Week Low Price | $0.22 | |||
| 52-Week Low Price (Date) | Sep 03, 2024 | |||
| 52-Week High Price (Date) | Apr 16, 2024 | |||
| Valuation | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 26.31M | |||
| Enterprise Value | 20.19M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.23 | |||
| Earnings Per Share Growth | 5.89% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 52.68 | |||
| Price/Book (Q) | 1.25 | |||
| Enterprise Value/Revenue (TTM) | 20.37 | |||
| Price | $0.29 | |||
| Enterprise Value/EBITDA (TTM) | -0.91 | |||
| Enterprise Value/EBIT | -1.08 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 177.77M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 214-845-5154 | |||
| Address | 555 Richmond Street West Toronto, ON M5V 3B1 | |||
| Website | perimetermed.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,887.54% | |||
| Profit Margin | -1,351.55% | |||
| Management Effectiveness | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -67.06% | |||
| Return on Equity | -- | |||
| Income Statement | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 846.10K | |||
| Total Revenue (TTM) | 991.00K | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 899.30K | |||
| EBITDA (TTM) | -22.22M | |||
| EBIT (TTM) | -18.71M | |||
| Net Income (TTM) | -13.39M | |||
| Net Income Avl. to Common (TTM) | -13.39M | |||
| Total Revenue Growth (Q YOY) | 211.41% | |||
| Earnings Growth (Q YOY) | 38.09% | |||
| EPS Diluted (TTM) | -0.23 | |||
| EPS Diluted Growth (Q YOY) | 9.94% | |||
| Balance Sheet | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.18M | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 9.97M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 10.45M | |||
| Current Ratio (Q) | 2.788 | |||
| Book Value Per Share (Q) | $0.23 | |||
| Total Assets (Q) | 14.33M | |||
| Total Current Liabilities (Q) | 3.58M | |||
| Total Debt (Q) | 137.50K | |||
| Total Liabilities (Q) | 3.87M | |||
| Total Common Equity (Q) | 10.45M | |||
| Cash Flow | PYNKF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.90M | |||
| Cash from Financing (TTM) | 8.58M | |||
| Net Change in Cash (TTM) | -7.80M | |||
| Levered Free Cash Flow (TTM) | -18.66M | |||
| Cash from Operations (TTM) | -14.72M | |||
